Fujiwara, I <br/><br/>
Soluble complement receptor type 1 and antithrombin-III combination therapy prolongs xenograft survival: the role of thrombin and prostacyclin in hyperacute rejection.  [electronic resource] 

 -  Transplantation proceedings   
 - 935-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(96)00256-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>6-Ketoprostaglandin F1 alpha--blood<br/>Animals<br/>Antigens, CD<br/>Antithrombin III--analysis<br/>Biomarkers--blood<br/>Graft Survival<br/>Guinea Pigs<br/>Heart Transplantation--immunology<br/>Humans<br/>Kinetics<br/>Male<br/>Myocardial Reperfusion<br/>Peptide Hydrolases--analysis<br/>Rats<br/>Rats, Inbred Strains<br/>Receptors, Complement 3b<br/>Time Factors<br/>Transplantation, Heterologous--immunology<br/>Transplantation, Isogeneic